An extended lymphadenectomy—removal of additional lymph nodes beyond the extent of the standard procedure—in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of ...

Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, indicate patients undergoing surgery for localized muscle-invasive bladder ...

Extended lymphadenectomy did not improve disease-free or overall survival compared to standard lymphadenectomy in muscle-invasive bladder cancer patients. Higher perioperative morbidity and mortality ...

A joint research team led by Professor Hyun-Woong Cho (Department of Obstetrics and Gynecology) and Professor Hyun Koo Kim (Department of Thoracic and Cardiovascular Surgery) at Korea University Guro ...

With the goals of informing surgical management, improving long-term outcomes and lowering death rates of patients with testicular cancer, a study has found that the conventional, versatile open ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

What to Expect ...

"In addition, survival rates after 44 months in these patients were excellent," said Dr Van Hemert. "The overall survival rate was 95%, and 89% of patients survived without a recurrence of invasive ...

Neoadjuvant chemoradiotherapy with ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial. This is an ASCO Meeting Abstract ...

SAN ANTONIO -- Thoracic surgeons were fired up about minimum expectations for surgical lymph node assessment in conjunction with lung cancer resection during a debate at the Society of Thoracic ...

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because ...